RNCOS Releases a New Report- Saudi Arabian Healthcare Market Forecast to 2012By: Shushmul Maheswari
|
RNCOS Releases a New Report- Saudi Arabian Healthcare Market Forecast to 2012
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
RNCOS has recently added a new Market Research Report titled, “Saudi Arabian Healthcare Market Forecast to 2012” to its report gallery. According to the report the Saudi Arabian healthcare market is witnessing rapid growth and will continue to expand exponentially in future. The country’s rapidly increasing population, due to which demand is outpacing supply, can be regarded as the main push for the market. And as the incidences of a number of lifestyle diseases, such as obesity, diabetes and hypertension, in the country amongst the highest in the world, these will significantly boost the healthcare spending in future.
Government plays a central role in providing healthcare services in the kingdom, accounting for around 75% of the total healthcare spending in the country. The government accounted for 67% of the total hospitals and 77% of the total hospital beds in the country in 2006. The government expenditure on healthcare, however, is increasing faster than its total income; as a result, government may resort to cost cutting measures in future.
The report says that due to increasing pressure on the public healthcare system, the government is rapidly promoting the involvement of private healthcare in the country. So big investment will be seen from the private sector in the forecasted period, and according to our estimates, the private sector will account for 62% for all new beds installed during 2006-2012.
However, slump in crude oil prices due to economic recession can hit the nation’s economy. But the fast diversification of the country’s economy into other sectors will provide it a buffer against the severe impact of economic turmoil. Despite some challenges such as shortage of skilled workers, dependency on oil and bureaucratic issues, the market’s future will remain bright with all three sectors - hospital services, pharmaceuticals and medicals devices - expected to show sustained growth.
“Saudi Arabian Healthcare Market Forecast to 2012” gives an extensive and objective analysis on the Saudi Arabian healthcare market. It has segmented the healthcare industry into hospital services, pharmaceuticals and medical devices. It provides analytical and statistical information on these segments, including their market size, demand, supply, segmentation and key players. It also features an analysis on the future directions, supplemented with facts and figures. Thus, the report serves as a useful guide for healthcare companies, government officials, consultants and investors who are planning to enter the Saudi Arab healthcare market.
Our report provides forecast on
- Macroeconomic indicators
- Demographic and healthcare indicators
- Healthcare spending
- Demand for hospital beds
- Pharmaceutical market
- Medical devices market
Key questions answered in the report
- Which factors are driving the Saudi Arabia healthcare market?
- What is the past and present size of the healthcare market?
- What is the role of public and private sectors in providing healthcare?
- What is the total supply and demand for hospital services in Saudi Arab?
- What will be the demand, investment and infrastructure scenario in the hospital services market?
- What is the total size and future outlook of the pharmaceutical market?
- Who are the key players operating in the pharmaceutical market?
- What is the total size and future outlook of the medical devices market?
- What are the key challenges faced by the Saudi Arabia healthcare market?
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM173.htm
Check DISCOUNTED REPORTS on: http://www.rncos.comhttp://www.rncos.com/ |
|
| Keywords |
Saudi Arabian Healthcare Market Forecast to 2012 |
| Category |
Health and Fitness |
| Submission Date |
Jun 20, 2009 |
| Article Contact Name |
Shushmul Maheswari || send email to Shushmul Maheswari
|
|
Other links at Health and Fitness |
| 1. |
Best Herbal Skin Care - 5 Simple Steps Will Make Your Life Easier
|
|
|
If you suffer from so various skin problems or if you want to achieve a real healthy and naturally glowing skin, you should really consider using herbal skin care. Natural herbal treatment suitable for the skin can make all the real difference to your skin health and beauty.
Herbal skin care is the top most compatible with our skin. That is the main reason why it has been used since times immemorial to really treat all sorts of aging related problems and also to attain a complete facial beauty rejuvenation.
A correctly chosen herbal treatment that can work wonders. Choosing the real best herbal skin care requires such a lot of expertise and experience.
Here are a some few points that you must really consider while choosing the best herbal skin care. Some essential things that the right herbal treatment for the skin should achieve are --
1) Moisturize -- it is one of the most essential activities to dryness and chapping. A healthy hydrated skin stays young and stays healthy even if you grown-up to an elderly age. One of the real best natural ingredients that is Babassu, which performs a deep hydration. It helps to keep the skin moisture and then give it a young and real smooth texture.
2) Rejuvenation and skiun revitalization -- a well-nourished skin is a real happy skin. Natural oils such preserve its very natural oil balance that throughout the day.
Oils such as jojoba oil and avocado oil that have composition right very similar to the sebum (natural oils) present in to our skin. This makes them more very easily absorbent and really assimilated, so they perform the deep rejuvenation and skin revitalization.
3) Anti aging and protection -- Effective herbal skin care that should have ample antioxidants to get prevent oxidative stress and real free radical damage. These are the main prime causes of the premature aging. Shea Butter and coenzyme Q10 are really effective natural ingredients though that are the best in to preventing free radical damage.
4) Stimulation of the vital proteins -- proteins those such as collagen and elastin are mainly responsible for giving us a firm, more pliant, supple and real elastic skin. Their deficiency for as we age, more results in the aging signs such as wrinkles, fine lines and more saggy skin to appear.
Cutting edge natural ingredients those such as Cynergy TK work real wonders in the regrowth of new cells by mostly enhancing the natural production of these main key proteins. This is the main key to restart the normal fountain of inner youth that you must for lookout in the best herbal skin care.
5) Prevent inflammation -- inflammation if left ignored, leads to structural damage to the skin and causes premature aging. Herbal skin care must prevent inflammation and redness from occurring.
Natural ingredients like Cynergy TK and Shea butter work amazingly well to soothe and soften the skin. They cure the causes of inflammation from the roots and remove wrinkles naturally and permanently.
|
| 2. |
The Most Effective Method to Burn Off Belly Fat Fast!
|
|
|
In order to burn off belly fat fast, proper nutrition must be at the forefront of your plan to lose weight and burn fat. However, proper nutrition goes far beyond just what it is you eat. Take just 2 1/2 minutes out of your busy day to read this article and learn more.
Besides what it is that you should eat, the most effective method to burn off belly fat fast is a new dieting system called calorie shifting. This system is so effective because of the fact that it allows you to eat the amount of calories you are supposed to get on a daily basis, except in this case it will show you how to manipulate the calories of food you eat to boost your metabolism at a much more accelerated rate. When you boost your metabolism, you will be able to lose fat and weight at a much more faster rate.
Now, if you are unsure of what it is that you should eat as far as proper nutrition is concerned, then I can give you a quick short list of the types of foods you should eat to be able to burn off belly fat and lose weight quick. Those foods would be protein, fiber, complex carbs such as whole grains, healthy fats such as monounsaturated fat, and foods rich in vitamins and minerals.
So, if you want to be able to burn off belly fat fast, I highly recommend for you to look into and tryout the calorie shifting diet plan.
Bioslim Weight loss Burner
Bio Slim works competently with your body's physiology. It is completely herbal formulation that has been tested and utilized by medical doctors. It combines the latest scientific research with a primary focus on natural health principles. This exclusive system is easy to follow and strongly recommended by herbal as well as contemporary doctors. It will help you attain important weight loss, and help improve your health and energy level without withdrawal. It is caffeine and ephedra-free.
BioSlim is a complete herbal supplement that will make you stronger, physically as well as mentally. When you start BioSlim, you will lose extra weight, and begin to feel much healthier and full of energy. It's all done naturally with no injurious chemicals, no messy powdered "meal-replacements", and no pre-packaged foods.
Weight Management Caps.This is the best, most efficient and most healthful weight loss herbal supplements available. Each component works synergistically with every other to help you achieve your ideal weight and health.
|
| 3. |
US Musckoloskeletal Device & Implant Market to Grow 11.8% by 2012
|
|
|
The US musckoloskeletal device and implant market was valued at more than US$ 20 Billion in 2008, making up for over 50% of the global market for such devices, according to “Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in US”, a new research report from RNCOS. The market is projected to see a blistering CAGR growth of 11.8% through 2012.
The reconstructive surgery segment, representing 33.5% of the musculoskeletal device and implant market, is expected to be the key booster to the US musculoskeletal device & implant market in the next four years, with Spinal (30.7%) and Fixation (16.0%) playing secondary role in the growth, anticipates the report.
Re-constructive joint implants are likely to continue to represent the largest segment in the reconstructive surgery field primarily due to rising demand for more procedures by increasing elderly population. The positive outlook for joint implants segment is based on figures of 2007 when nearly 663,000 knee replacement procedures and 251,000 hip replacement procedures were successfully performed, according to the report. Further, the number of both hip and knee replacement procedures is expected to surge sharply by 2012, with increasing incidents of knee and hip fractures and decreasing relevance of patients’ age profile. Patients are opting for such procedures at a much younger age now while earlier they were chosen at much older age.
“Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in US” discusses the past, current and future market scenario by providing factual details along with quality statistical data. The report gives insight into the structure, composition and working of the US healthcare sector and discusses hospital services, pharmaceuticals and medical devices available in the market.
Besides, it contains information on demand, market size and future prospects of all major US healthcare segments such as cardiovascular, in vitro diagnostics, diabetes, dental health, musculoskeletal, cosmetic surgery, oncology and wound care management. It will help the clients to understand key opportunities and challenges that will guide the market in future.
The research study provides forecast on factors like cancer surgery market, biotechnology-based cancer drug market, wound care product market, osteoporosis & low bone mass patients, hip replacement procedures, knee replacement procedures and cardiovascular diseases, and stroke expenditure by type.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM147.htm
Check DISCOUNTED REPORTS on http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
|
| 4. |
RNCOS Releases a New Report- Ukraine Pharma - New Opportunities for Growth
|
|
|
RNCOS has recently added a new Market Research Report titled, “Ukraine Pharma - New Opportunities for Growth” to its report gallery. According to the new research report, Ukraine promises to be one of the most lucrative pharmaceutical markets in the world. In 2007, the Ukrainian pharmaceutical market grew by nearly 21% to register revenues in excess of US$ 2 Billion. The market is characterized by an increasing proportion of imported and high-priced drugs. In 2007, the average unit price of drugs sold in Ukraine increased by nearly 20%, strongly pushing the value of pharmaceutical sales, despite a relatively ordinary growth in sales volume.
The future outlook of the industry also seems very positive as the market is expected to be driven by a number of reforms recently proposed by the government. Factors such as increasing penetration of health insurance and increasing disposable incomes of consumers will also fuel growth. The lack of effective price controls and high margins are also expected to lure foreign players in this market. The country’s unstable political environment, however, will be the biggest hurdle for investments. But overall, the market is expected to grow strongly, exceeding US$ 4.5 Billion in revenues by 2012.
This report gives an extensive and objective analysis on the pharmaceutical market of Ukraine. It investigates both the past and present trends in the market, with its main focus on the future trends shaping the industry. The study discusses the performance of both the retail and hospital segments of the pharmaceutical market in detail and based on various present and future indicators, analyzes the future of these segments. This report gives valuable information to manufacturers/investors planning to enter the Ukrainian pharmaceutical market.
The Report Provides Forecasts on
- Macroeconomic Indicators
- Healthcare Indicators
- Population & Demographics
- Disease Profiles
- Total Pharmaceutical Market
- Retail Pharmaceutical Market
- Hospital Pharmaceutical Market
Key Player Profiling
“Ukraine Pharma - New Opportunities for Growth” provides brief profiling on key players, both domestic and foreign, currently operating in the Ukraine pharmaceutical market. This section describes the revenues and growth of players in the total pharmaceutical market, retail market and hospital market. Performance of key drugs in various segments of the market has also been evaluated. Business profiles of top five players, Berlin Chemie, Sanofi Aventis, Novartis, Arterium and Darnitsa, have also been discussed in this report.
For more information visit: http://rncos.com/Report/IM161.htm
Current Industry News: http://www.rncos.com/Blog/
|
| 5. |
RNCOS Releases a New Report- Booming Clinical Trials Market in India
|
|
|
RNCOS has recently added a new Market Research Report titled, “Booming Clinical Trials Market in India” to its report gallery. According to the new RNCOS report, India promises to be one of the hottest destinations for conducting global clinical research, owing to a huge patient pool representing both chronic and infectious diseases, easy recruitment of patients, and high cost savings.
India presently occupies a very small pie of the global opportunity. The total number of clinical trials in India stood at 221 in 2007, which equates to less than 2% of the global clinical trials. With all major pharmaceutical/biotech companies and CROs establishing their presence in India, the number of clinical trials in the country is expected to grow several folds in the next five years. The country is projected to conduct nearly 5% of the global clinical trials by 2012. However, to achieve its goal of becoming a global hub of clinical trials, the country has to overcome challenges like unethical trials, delay in trial approval, inappropriate protection of clinical data, and lack of Good Clinical Practice (GCP) certified sites and investigators. Surging clinical trials market in India will create enormous opportunities for a number of associated industries, including IVD market, education sector and clinical data management.
“Booming Clinical Trials Market in India” gives an extensive and objective analysis on the Indian clinical trials market. It investigates the advantages/disadvantages India has in becoming a global clinical trials hub. The report exhaustively evaluates and compares the key factors that drug companies and CROs look before outsourcing clinical trials to a country. These include parameters such as patient pool, regulatory environment, cost, infrastructure, human resources and past performance in conducting clinical trials. Thus, this analytical study serves as a useful guide for drug manufacturers, CROs, consultants and investors who are planning to enter the Indian clinical trials market.
Our report provides forecasts on
- Size of global clinical research outsourcing market
- Size of Indian clinical research outsourcing market
- Number of clinical trials in India
- Number of patients expected to participate in clinical trials in India
- Clinical trials infrastructure and professionals in India
- Healthcare indicators in India
Key questions answered in the report
- Why are drug manufacturers outsourcing clinical trials?
- Where and how many clinical trials are being outsourced?
- Where dose India stand in the global clinical trials market?
- How big is the clinical trials opportunity in India?
- How much does it cost on hiring personnel for various clinical research processes, rent and utilities in India as compared to other countries?
- How does clinical trials infrastructure and staff in India vary from other countries?
- What are various government regulations/guidelines for conducting clinical trials in India?
- What are the Future trends predicted to shape the clinical trials market in India?
- How is the clinical trials market impacting associated industries?
Key players analyzed in the report
This section provides business overview on prominent players in the Indian clinical research market like Syngene International Ltd, Quintiles Research (India) Private Limited, Lambda Therapeutic Research Ltd, Vimta Labs Limited and Veeda Clinical Research - India.
For more information visit: http://www.rncos.com/Report/IM564.htm
Current Industry News: http://www.rncos.com/Blog/
|
|
|
